SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders.

Biotechnology

Sage Therapeutics

Sage Therapeutics' headquarters in Cambridge, MA, United States

The Raleigh office focuses on pharmaceutical development, quality compliance, and patient support services.

Raleigh

Barry E. Greene

Kevin Kendall

Tammy Phinney

Jessica Johnson Brock

Lisa Lopez

Taryn Westerkamp

Erin Flaherty

Jason Valdivia

Anne Marie Cook

Ruta Sawant

Etchell Cordero

Matthew Henson

Liz Barrett

Michael F. Cola

James M. Frates

George Golumbeski

Jessica Federer

The Data Management and Analysis team at Sage Therapeutics is responsible for overseeing the integrity and quality of clinical data throughout the drug development process. This team collaborates with clinical operations, biostatistics, and digital integration teams to ensure accurate data collection, analysis, and reporting for CNS disorder treatments. They leverage advanced data science techniques to derive insights and support decision-making, ultimately enhancing the efficiency and effectiveness of clinical trials.

Data Management and Analysis

This department focuses on managing and delivering neuropsychological services and support for patients.

Neuropsychology Services

The Market Access and Patient Support team at Sage Therapeutics focuses on ensuring that patients have timely access to innovative CNS therapies. They develop strategies for market access, engage with payers and healthcare providers, and implement patient support programs tailored to optimize the treatment journey. This collaborative team works to navigate reimbursement processes, enhance patient recruitment and retention, and ensure compliance, ultimately aiming to improve patient outcomes and healthcare accessibility.

Market Access and Patient Support

The Clinical Operations and Development team at Sage Therapeutics is focused on managing and executing clinical trials for innovative CNS therapies. This team coordinates study protocols, oversees regulatory compliance, collaborates with external partners, and ensures that clinical data is accurately collected and analyzed to support the development of effective treatments. Additionally, they work on optimizing operational processes to enhance efficiency and streamline communication among stakeholders throughout the clinical development lifecycle.

Clinical Operations and Development

The Leadership Team at Sage Therapeutics plays a critical role in guiding the company's strategic direction and operational effectiveness in the development of treatments for CNS disorders. Comprising executives from various disciplines, including research and development, legal, business operations, and human resources, this team collaborates to ensure alignment with the company’s mission, oversee the advancement of innovative therapies, and foster a culture of excellence and collaboration within the organization.

Leadership Team

This department oversees the planning, execution, and management of clinical trials and drug development processes.

Sage Therapeutics

Org chart

Board & advisors

Teams

Data Management and Analysis

Neuropsychology Services

Market Access and Patient Support

Clinical Operations and Development

Leadership Team

Clinical Development

Offices

Sage Therapeutics

Org chart

Board & advisors

Teams

Data Management and Analysis

Neuropsychology Services

Market Access and Patient Support

Clinical Operations and Development

Leadership Team

Clinical Development

Offices

Related companies